Trending/Base inhibitors
Alzheimer’s disease drug fails in trial
Merck is halting a trial of verubecestat, an Alzheimer's disease medication. The pharmaceuticals company concluded the drug has “virtually no chance of finding a positive clinical effect.”…
No information found.
Special Topics
Sign up
Mayo Clinic Connect
An online patient support community